| Lang Counseling And Consulting Group, Llc | |
|
1290 Cedar Center Dr Tallahassee FL 32301-4876 | |
| (850) 665-0027 | |
| (850) 792-6084 |
| Full Name | Lang Counseling And Consulting Group, Llc |
|---|---|
| Speciality | Social Worker |
| Location | 1290 Cedar Center Dr, Tallahassee, Florida |
| Authorized Official Name and Position | Jouasha Keywona Lang (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 8506650027 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lang Counseling And Consulting Group, Llc Po Box 1061 Midway FL 32343-1061 Ph: (850) 665-0027 | Lang Counseling And Consulting Group, Llc 1290 Cedar Center Dr Tallahassee FL 32301-4876 Ph: (850) 665-0027 |
| NPI Number | 1821452913 |
|---|---|
| Provider Enumeration Date | 04/05/2016 |
| Last Update Date | 04/05/2016 |
| Medicare PECOS PAC ID | 4486047560 |
|---|---|
| Medicare Enrollment ID | O20220214001097 |
News Archive
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.
Pro-Amino International Inc. is recalling protein bars which may contain Salmonella. The product is the ProtiDiet High Protein Chocolate Dream Bar, sold in 210 gram (7.4 oz.) packages, 7 bars per package, bearing UPC 6 21498 42238 1, lot code CR 18 13B, and Best Before date of 2015-08.
Nanobiotix has announced that an independent preclinical study has validated the applicability of using its nanoparticles-nanoPDT-to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the Company focuses development efforts on its nanoXray technology.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research and a leading provider of software solutions designed to accelerate clinical trials safely, announced today that its New England Institutional Review Board has been reaccredited by the Association for the Accreditation of Human Research Protection Programs.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821452913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SW12760 (Florida) | Primary |
| Provider Name | Jouasha Lang |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1861748477 PECOS PAC ID: 6103135603 Enrollment ID: I20220214001192 |
News Archive
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.
Pro-Amino International Inc. is recalling protein bars which may contain Salmonella. The product is the ProtiDiet High Protein Chocolate Dream Bar, sold in 210 gram (7.4 oz.) packages, 7 bars per package, bearing UPC 6 21498 42238 1, lot code CR 18 13B, and Best Before date of 2015-08.
Nanobiotix has announced that an independent preclinical study has validated the applicability of using its nanoparticles-nanoPDT-to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the Company focuses development efforts on its nanoXray technology.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research and a leading provider of software solutions designed to accelerate clinical trials safely, announced today that its New England Institutional Review Board has been reaccredited by the Association for the Accreditation of Human Research Protection Programs.
› Verified 8 days ago
News Archive
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.
Pro-Amino International Inc. is recalling protein bars which may contain Salmonella. The product is the ProtiDiet High Protein Chocolate Dream Bar, sold in 210 gram (7.4 oz.) packages, 7 bars per package, bearing UPC 6 21498 42238 1, lot code CR 18 13B, and Best Before date of 2015-08.
Nanobiotix has announced that an independent preclinical study has validated the applicability of using its nanoparticles-nanoPDT-to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the Company focuses development efforts on its nanoXray technology.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research and a leading provider of software solutions designed to accelerate clinical trials safely, announced today that its New England Institutional Review Board has been reaccredited by the Association for the Accreditation of Human Research Protection Programs.
› Verified 8 days ago
Seasons Of Life Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 113 S Monroe St, Tallahassee, FL 32301 Phone: 850-201-7177 Fax: 850-201-7101 | |
Tallahassee Neurology Associates, P.a. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2868 Mahan Dr, Suite 5, Tallahassee, FL 32308 Phone: 850-942-7177 Fax: 850-656-9443 | |
Psychiatry Associates Of Tallahassee, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1407 M D Ln Ste A, Tallahassee, FL 32308 Phone: 850-877-0635 Fax: 850-205-0195 | |
Dna Comprehensive Therapy Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1965 Capital Cir Ne Ste 102, Tallahassee, FL 32308 Phone: 850-671-4600 | |
Renewing Minds Counseling And Consulting Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4047 Ailanthus Ct, Tallahassee, FL 32305 Phone: 850-692-9268 | |
Dr. Peter Debelius-enemark, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1407 M D Ln Ste A, Tallahassee, FL 32308 Phone: 850-877-0635 Fax: 850-205-0195 | |
Tallahassee Therapy Associates, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 W 4th Ave, Tallahassee, FL 32303 Phone: 850-241-5707 |